GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Annals of Clinical Hypertension, Heighten Science Publications Corporation, Vol. 7, No. 1 ( 2023-03-16), p. 001-003
    Abstract: Hypertension is a risk factor for the development of heart failure and has a negative impact on the survival of these patients. Although patients with these two conditions usually take different antihypertensive medications, some patients do not achieve adequate blood pressure control and their hypertension becomes resistant or refractory. In this scenario, percutaneous renal denervation has emerged in recent years as an alternative to achieve blood pressure control goals. We present the case of a 53-year-old woman with a medical history of essential hypertension, hypercholesterolemia, unipolar depression, and diabetes, who was diagnosed with dilated cardiomyopathy with reduced left ventricular ejection fraction (33%). Despite the initiation of multiple antihypertensive medications and placement of a cardiac resynchronization therapy pacemaker, the patient remained hypertensive with a left ventricular ejection fraction of 40%. At that time, percutaneous renal denervation was performed without complications, and one year after the procedure, the patient had improved better blood pressure control and the left ventricular ejection fraction increased to 51%. This case illustrates one of the clinical scenarios in which it has been suggested that renal denervation may be more beneficial, as in the situation of patients with refractory hypertension and heart failure.
    Type of Medium: Online Resource
    ISSN: 2639-6629
    Language: Unknown
    Publisher: Heighten Science Publications Corporation
    Publication Date: 2023
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 38, No. Supplement_1 ( 2023-06-14)
    Abstract: The decrease of immunosuppression (IS) in kidney transplant (KT) recipients with SARS-CoV-2 infection was proposed during the first years of the pandemic due to the lack of knowledge of the course of the infection and the absence of vaccines and specific treatment. The effects of this decrease are being assessed in a medium-long term. Method Unicentric retrospective study that included 19 patients with a kidney biopsy after a SARS-CoV-2 infection (120 days). We measured acute kidney injury (AKI) after de infection, decrease in the IS during the infection, rejection episodes and renal function evolution during 24 months after the infection. Results The studied group was constituted by 19 patients from which 57.9% (11/19) men, age 56 (51, 70), being the first KT in 78.9% (15/19) of them. The IS induction was in a 57.9% (11/19) Basilximab and in a 42.1% (8/19) thymoglobulin, and the usual IS of all of them was done with prednisone, tacrolimus and mycophenolic acid. There was a graft loss in 26.3% (5/19), being all of immunologic cause, and 10.5% (2/19) of patients died. The severity of the SARS-CoV-2 infection was different between patients (21.1% (4/11) asymptomatic, 47.1% (9/19) mild respiratory symptoms, 5.3% (1/19) severe pneumonia not requiring critical care unit and 26.3% (5/19) severe pneumonia requiring critical care unit, with a decrease in IS in a 42% (8/19) of patients (steroids in monotherapy in a 31.6% (6/19) and bitherapy with steroids and tacrolimus in a 10,5% (2/19), to achieve 5-7ng/mL blood levels). AKI was found after the first month after the infection in a 57.9% (11/19) of patients, being in a 42% (8/19) AKI KDIGO1 and in a 16% (3/19) AKI KDIGO3. Renal function kept worsening until the sixth month after the infection [CKDEPI before SARS-CoV-2 37mL/min (32, 45) vs CKDEPI 6months after 34mL/min (22, 48.3); p = 0.3]. There was an improvement in renal function in 12 months after the infection (38mL/min (25, 48)). Acute graft rejection was detected in renal biopsies after the infection in 31.6% (6/19) being cellular in 15.8% (3/19), humoral in 10.5% (2/19) and mixed in 5.3% (1/19), de novo DSA were found in 15.8% (3/19). Conclusion The decrease in IS after SARS-CoV-2 in KT recipient has an elevated immunologic price. Glomerular filtrate rate decreases after 6 months from infection with a recovery at 1 year.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2023
    detail.hit.zdb_id: 1465709-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 38, No. Supplement_1 ( 2023-06-14)
    Abstract: Kidney transplantations (KT) from uncontrolled donation after cardiac death (uDCD) achieve very good outcomes to short and long follow-up, but the incidence of primary non-function and venous thrombosis (VT) is very high. The resistance index (RI) after kidney transplantation increase in the VT cases and in other kidney diseases. Aims To describe the effect of prophylactic anticoagulation in KT from uDCD with RI ≥0.8 to avoid VT and its secondary effect. Method Unicentric retrospective cohorts study that included all KT from uDCD with RI ≥0.8 measured by ecodoppler in the first 72 hours post-transplantation. We compared one group, which never received anticoagulation (Group I), and a second one which received prophylactic anticoagulation (Group II). Sodic heparin was the administer anticoagulant to achieve aPTT 1.5-2 time normal range and/or low molecular weight heparin adjusted to patient's weight and renal function. Results We included 107 KT from uDCD with RI≥0.8, with 36 in Group I and 76 in Group II. In Group I the donors were younger (39 ± 12 vs 46 ± 8; p = 0.003) and there were more men donors (97.2% vs 81.7%; p = 0.032). The prevalence of VT was higher in Group I (19.4% vs 0%; p & lt;0.001). Patients in Group II needed more red blood transfusions (19.4% vs 39.4%; p = 0.05) and had more macroscopic haematuria (5.6% vs 21.1%; p = 0.049). The competing risk analysis showed a higher probability to develop a VT in non-anticoagulation group (p = 0.00012) than anticoagulation group or other causes of primary non-function (Figure 1). Conclusion The prophylactic anticoagulation treatment in KT from uDCD with RI≥0.8 decreases the VT incidence and it is safe for a donor recipient.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2023
    detail.hit.zdb_id: 1465709-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 38, No. Supplement_1 ( 2023-06-14)
    Abstract: Acute kidney injury (AKI) is a common complication in the critically ill and non-critically ill patient. There is currently no specific treatment for patients who develop AKI, so early recognition may help prevent progression to more advanced stages and the need for kidney replacement therapies (KRT). Electronic Alert Systems (EAS) emerge as a useful tool in different clinical scenarios to alert the clinician to potentially harmful situations. One of the utilities of the EAS is the AKI scenario, in which the clinician can be alerted early to serum creatinine (SCr) changes in real time and thus establish early intervention protocols to avoid the poor outcomes described above. The aim of the present study is to analyze the incidence of AKI in a tertiary hospital using an EAS based on SCr changes (Electronic Creatinine Alert System -ECAS-). Method Retrospective study conducted in a tertiary referral hospital. All discharges of patients over 18 years of age, which were issued from 1 January 2019 to 31 December 2021, were analyzed. Exclusion criteria were: discharges from critical care units, patients admitted to the emergency room, patients with AKI criteria on admission, patients admitted to the nephrology department and patients with CKD G5 or on KRT. The ECAS was developed with the aim of alerting patients with and increase of ≥ 0.3mg/dL of SCr or an elevation of ≥ 1.5 times the baseline creatinine value, based on AKI SCr from the KDIGO guidelines. The aims of the present study were: 1. Number of hospitals discharges that activated the ECAS, as well as the severity of AKI; 2. Categorize the departments in which ECAS was common; and 3. Assessing length of hospital stay, survival and kidney recovery during admission defined as SCr less than 1.5 times baseline. Results A total of 69,002 discharges were analyzed over 3 years. Finally, 46,149 discharges were included in the analysis, of which 5,593 (13.5%) discharges activated the ECAS. The distribution by year in which the ECAS was activated was 1,788 (11,8%) of all discharges in 2019, 1,860 (12,4%) in 2020 and 1,945 (12,1%) in 2021. The median age was 75 years (65 – 83), 62% were male. The 5 departments with the highest number of ECAS activations were: Geriatric (14.2%), Cardiology (11.9%), General Surgery (9.9%), Infectious Diseases (9.2%) and Cardiac Surgery (7.6%). Baseline SCr was 1.12mg/dL (0.80-1,79), maximum SCr was 1.99mg/dL(1.40 - 3.19) and SCr at discharge was 1.39 (0.96 - 2.23). 69,7% of patients had AKI stage 1, 21,3% had AKI stage 2 and finally 9% had AKI stage 3. Length of hospital stay was significantly elevated in patients who activated the ECAS [6 days (3 - 11) vs. 13 (8 - 22); p: & lt;0.001], the survival distributions for the ECAS activation were statistically different, X2 (2) = 5.522, p: 0.019. Finally, kidney recovery at discharge was significantly lower in AKI 2 (18.5%) and AKI 3 (8.5%) patients compared to AKI 1 patients (73%) (p: & lt;0.001 for all). Conclusion The ECAS is a suitable electronic alert system that allows rapid identification of patients with AKI. The activation of ECAS is associated with poor outcomes. This study led to the adoption of a nephrology rapid response team for early detection of AKI before creatinine elevation using among others Point-of-care ultrasonography and acute kidney stress biomarkers.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2023
    detail.hit.zdb_id: 1465709-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...